首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1741543

全球肿瘤人工智慧市场：按成分、按癌症类型、按治疗类型、按最终用户、按地区

Global Artificial Intelligence in Oncology Market, By Component, By Cancer Type, By Treatment Type, By End User, By Region

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球肿瘤人工智慧市场规模估计为 21.451 亿美元，预计到 2032 年将达到 163.82 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 33.7%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	21.451亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	33.70%	2032年价值预测	163.82亿美元

人工智慧 (AI) 在肿瘤学中发挥关键作用。有各种类型的 AI 产品可协助进行癌症筛检、诊断、治疗和药物开发。其中一个主要产品是 AI 癌症筛检工具。这些工具使用在庞大的医学影像资料库上训练的深度学习演算法。它们可帮助医生检测 CT、MRI 和乳房 X 光检查等扫描影像中的异常。它们可以快速分析大量影像并突出显示医生仅靠人工筛检可能遗漏的可疑区域。这提高了早期肿瘤检测的准确性并挽救了更多生命。然而，需要不断更新新数据以改进演算法。由于 AI 可能无法有效区分罕见癌症类型，因此也存在误诊的风险。

另一个重要应用是人工智慧在癌症诊断、预后和治疗的应用。透过对海量基因组和临床癌症资料集进行机器学习，人工智慧能够识别复杂模式，获得新见解，并比人类更好地预测治疗反应。这有助于客製化标靶治疗。人工智慧也透过辅助标靶识别、化合物筛检和优化临床试验来加速药物开发。

市场动态：

癌症发生率的上升和癌症治疗决策的日益复杂是推动肿瘤学采用人工智慧解决方案的主要驱动力。数位健康数据和运算能力的日益普及正在推动先进人工智慧技术的发展。然而，开发高精度临床级人工智慧解决方案所需的高额投资和成本是限制其发展的主要因素。对人工智慧决策机制的缺乏解读和理解也限制了其广泛应用。另一方面，人工智慧透过实现个人化治疗方案选择，有望帮助克服抗药性，这为未来带来了机会。科技公司与研究机构之间的伙伴关係旨在进一步检验人工智慧的临床应用价值。

从地区来看，北美凭藉其高昂的医疗成本和便利的医疗服务占据市场主导地位。然而，亚太地区是成长最快的市场，主要由中国和印度等国家推动。这一增长得益于经济成长、可支配收入的增加、医疗基础设施的扩张以及先进癌症诊断工具的普及。

本研究的主要特点

本报告对全球肿瘤学人工智慧市场进行了详细分析，并以 2024 年为基准年，提供了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球肿瘤人工智慧市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球肿瘤学人工智慧市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
透过用于分析全球肿瘤学人工智慧市场的各种策略矩阵，相关人员可以更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2,145.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	33.70%	2032 Value Projection:	USD 16,382.0 Mn

Artificial intelligence (AI) plays an important role in oncology. There are various types of AI products that are helping in cancer screening, diagnosis, treatment, and drug development. One of the major products is an AI-assisted cancer screening tool. These tools use deep learning algorithms that have been trained on huge databases of medical images. They help physicians detect abnormalities in scans like CT, MRI, or mammograms. They can rapidly analyze a large number of images and highlight suspect areas that the doctor may miss with human screening alone. This improves the accuracy of detecting tumors at early stages and increases the number of lives saved. However, the algorithms need continuous updates with new data to improve over time. Misdiagnosis is also a risk because the AI may not be able to distinguish rare cancer types effectively.

Other important applications include the use of AI in cancer diagnostics, prognosis, and therapeutics. Using machine learning on vast pools of genomic and clinical cancer datasets, AI can recognize complex patterns, emerge with new insights, and predict treatment responses better than humans. This helps with customized and targeted therapy. AI is also speeding up drug development by assisting in target identification, compound screening, and clinical trial optimization.

Market Dynamics:

Rising cancer incidence coupled with the increasing complexity of cancer treatment decisions is a key factor driving the adoption of AI solutions in oncology. The growing availability of digital health data and computational power is facilitating the development of advanced AI technologies. However, the high investment and costs required for the development of precision and clinical-grade AI solutions are a major restraint. Lack of interpretability and understanding of how AI arrives at its decisions also limits widespread adoption. Meanwhile, the potential of AI to help overcome drug resistance by enabling personalized treatment selection presents an opportunity. Partnerships between technology companies and research institutes aim to further validate the clinical applicability of AI.

Among regions, North America dominates the market due to high healthcare expenditures and better access to care. However, Asia Pacific is poised to be the fastest-growing market arena, led by countries like China and India. This growth can be attributed to growing economies, rising disposable incomes, expanding medical infrastructure, and the increasing adoption of technologically advanced cancer diagnostic tools.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence in oncology market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial intelligence in oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI, Microsoft, Zebra Medical Vision, and Babylon
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global artificial intelligence in oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in oncology market

Global Artificial Intelligence in Oncology Market Segmentation:

By Component
- Software/Platform
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others
By Treatment Type
- Chemotherapy
- Radiotherapy
- Immunotherapy
- Others
By End User:
- Hospitals & Clinics
- Diagnostic Centers
- Biopharmaceutical Companies
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Azra AI
- IBm Corporation
- Siemens Healthineers AG
- Intel Corporation
- GE HealthCare
- NVIDIA Corporation
- Digital Diagnostics Inc.
- ConcertAI
- Median Technologies
- PathAI
- Microsoft
- Zebra Medical Vision
- Babylon

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Top 3 Market Findings
- Top 3 Market Opportunity

3. Key Industry Insights

Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancement
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals/Launches
Company Market Share Analysis

4. Artificial Intelligence In Oncology Market, By Component Type, 2020 - 2032 ( US$ Million)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
- Segment Trends
Software Solutions, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Hardware, 2020 - 2032( US$ Million
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Services, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

5. Artificial Intelligence In Oncology Market, By Cancer Type, 2020 - 2032 ( US$ Million)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
- Segment Trends
Breast Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Lung Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Prostate Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Colorectal Cancer, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Brain Tumor, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Others, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

6. Artificial Intelligence In Oncology Market, By Treatment Type, 2020 - 2032 ( US$ Million)

Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
- Segment Trends
Chemotherapy, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Radiotherapy, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Immunotherapy, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Others, 2020 - 2032( US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

7. Artificial Intelligence In Oncology Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2020 - 2032, ( US$ Million)
- Segment Trends
By Region
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
North America
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - U.S.
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Canada
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Europe
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - U.K
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Germany
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
France
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Italy
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Spain
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Russia
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Europe
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Asia Pacific
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - China
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
India
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Japan
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Australia
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
South Korea
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
ASEAN
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Asia Pacific
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Latin America
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - Brazil
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Mexico
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Argentina
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Latin America
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Middle East
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - GCC
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Israel
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Rest of Middle East
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Africa
- Introduction
- Market Size and Forecast, By Component Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Cancer Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, ( US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, ( US$ Million)
  - North Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
Central Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)
South Africa
- Introduction
- Market Size and Forecast, 2020 - 2032, ( US$ Million)

8. Company Profiles - Artificial Intelligence In Oncology Market

NVIDIA Corporation
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Digital Diagnostics Inc.
ConcertAI
Median Technologies
PathAI
Azra AI
IBM
Siemens Healthcare GmbH

9. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

全球肿瘤人工智慧市场：按成分、按癌症类型、按治疗类型、按最终用户、按地区